scholarly journals Functional characterization of the biogenic amine transporters on human macrophages

JCI Insight ◽  
2022 ◽  
Author(s):  
Phillip M. Mackie ◽  
Adithya Gopinath ◽  
Dominic M. Montas ◽  
Alyssa Nielsen ◽  
Aidan Smith ◽  
...  
2014 ◽  
Vol 446 (3) ◽  
pp. 663-668 ◽  
Author(s):  
Inga Preuss ◽  
Marie-Gabrielle Ludwig ◽  
Birgit Baumgarten ◽  
Frederic Bassilana ◽  
Francois Gessier ◽  
...  

2021 ◽  
Author(s):  
Phillip M Mackie ◽  
Adithya Gopinath ◽  
Dominic M Montas ◽  
Alyssa Nielsen ◽  
Rachel Nolan ◽  
...  

AbstractMonocyte-derived macrophages are key players in tissue homeostasis and disease regulated by a variety of signaling molecules. Recent literature has highlighted the ability for biogenic amines to regulate macrophage functions, but the mechanisms governing biogenic amine signaling on and around immune cells remains nebulous. In the central nervous system, biogenic amine transporters are regarded as the master regulators of neurotransmitter signaling. While we and others have shown macrophages express these transporters, relatively little is known of their function on these cells. To address these knowledge gaps, we interrogated the function of norepinephrine (NET) and dopamine (DAT) transporters on human monocyte-derived macrophages. We found that both NET and DAT are present and can uptake substrate from the extracellular space at baseline. Not only was DAT expressed in cultured macrophages, but it was also detected in a subset of intestinal macrophages in situ. Surprisingly, we discovered a NET-independent, DAT-mediated immuno-modulatory mechanism in response to lipopolysaccharide (LPS). LPS induced reverse transport of dopamine through DAT, engaging autocrine/paracrine signaling loop that regulated the macrophage response. Removing this signaling loop enhanced the pro-inflammatory response to LPS. Finally, we found that this DAT-immune axis was disrupted in disease. Collectively, our data introduce a novel role for DAT in the regulation of innate immunity during health and disease.


Synapse ◽  
2002 ◽  
Vol 44 (2) ◽  
pp. 94-105 ◽  
Author(s):  
Richard B. Rothman ◽  
F. Ivy Carroll ◽  
Marisela Morales ◽  
Daniel L. Rowley ◽  
Kenner C. Rice ◽  
...  

2020 ◽  
Vol 477 (7) ◽  
pp. 1261-1286 ◽  
Author(s):  
Marie Anne Richard ◽  
Hannah Pallubinsky ◽  
Denis P. Blondin

Brown adipose tissue (BAT) has long been described according to its histological features as a multilocular, lipid-containing tissue, light brown in color, that is also responsive to the cold and found especially in hibernating mammals and human infants. Its presence in both hibernators and human infants, combined with its function as a heat-generating organ, raised many questions about its role in humans. Early characterizations of the tissue in humans focused on its progressive atrophy with age and its apparent importance for cold-exposed workers. However, the use of positron emission tomography (PET) with the glucose tracer [18F]fluorodeoxyglucose ([18F]FDG) made it possible to begin characterizing the possible function of BAT in adult humans, and whether it could play a role in the prevention or treatment of obesity and type 2 diabetes (T2D). This review focuses on the in vivo functional characterization of human BAT, the methodological approaches applied to examine these features and addresses critical gaps that remain in moving the field forward. Specifically, we describe the anatomical and biomolecular features of human BAT, the modalities and applications of non-invasive tools such as PET and magnetic resonance imaging coupled with spectroscopy (MRI/MRS) to study BAT morphology and function in vivo, and finally describe the functional characteristics of human BAT that have only been possible through the development and application of such tools.


Sign in / Sign up

Export Citation Format

Share Document